Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Zusätzlich bieten wir Ihnen LGALS7 Antikörper (48) und LGALS7 Proteine (11) und viele weitere Produktgruppen zu diesem Protein an.
Showing 3 out of 8 products:
The data suggest that gal-7 could potentiate the phenotype of HER-2 (zeige ERBB2 ELISA Kits) positive primary breast cancer.
results indicate that an excess of galectin-7 leads to a destabilisation of adherens junctions associated with defects in epidermal repair
Overexpression of galectin-7 increased the resistance of melanoma cells to apoptosis while inducing de novo egr-1 (zeige EGR1 ELISA Kits) expression.
In cardiac transplantation galectin-7 relates to acute allograft rejection and T-cell responses possibly as an accelerant.
Extracellular superoxide dismutase (zeige SOD3 ELISA Kits) plays a role not only as a reactive oxygen species scavenger, but also as a pro-apoptotic factor via COX-2 (zeige COX2 ELISA Kits)/galectin-7 pathways in the epidermis.
Galectin-7 modulates the length of the primary cilia and wound repair in polarized kidney epithelial cells.
Data show that high levels of galectin-7 expression in breast cancer cells drastically increased their ability to metastasize to lungs and bones, and were restricted to high-grade breast carcinomas.
Galectin-3 (zeige LGALS3 ELISA Kits) and galectin-7 play a role in corneal epithelial wound healing.
Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.
Galectin-7 promotes maliganacy by upregulating MMP-9 (zeige MMP9 ELISA Kits) gene expression.
Data suggest that evaluation of galectin-7 could help guide postsurgical management for non-metastatic clear cell renal cell carcinoma (ccRCC).
these findings reveal the existence of a positive self-amplification pathway that regulates intracellular gal-7 expression in breast and ovarian cancer cells.
Gal-7 re-expression affects the regulation of molecular networks in cervical cancer that are involved in diverse cancer hallmarks, such as metabolism, growth control, invasion and evasion of apoptosis
It is a beta-galactose-binding animal lectin and known to be distributed throughout the body.
Data indicate that the galectin inhibitor specifically binds galectin-7 (hGal (zeige GCET2 ELISA Kits)-7), disrupts the formation of homodimers, and inhibits the pro-apoptotic activity of hGal (zeige GCET2 ELISA Kits)-7 on Jurkat T cells.
Galectin-7 regulates keratinocytes proliferation and differentiation through JNK1 (zeige MAPK8 ELISA Kits) pathway.
The assessment of a carbohydrate-recognition domain (CRD (zeige CRX ELISA Kits))-defective mutant form of gal-7 (R7S) showed that the ability of this protein to modulate apoptosis was independent of its CRD (zeige CRX ELISA Kits) activity.
our study validates the clinical significance of gal-7 overexpression in ovarian cancer
Cytosolic galectin-7 impairs p53 (zeige TP53 ELISA Kits) functions and induces chemoresistance in breast cancer cells.
Galectin-7 is produced by the premenstrual and menstrual endometrium, where it accumulates in menstrual fluid and likely acts as a paracrine factor to facilitate post-menstrual endometrial re-epithelialization.
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Differential and in situ hybridization studies indicate that this lectin is specifically expressed in keratinocytes and found mainly in stratified squamous epithelium. A duplicate copy of this gene (GeneID:653499) is found adjacent to, but on the opposite strand on chromosome 19.
, galectin 7
, lectin, galactose binding, soluble 7